SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS) Article / By Wiley Knowledge Hub SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS) Read More »
Characteristic findings of primary perirenal angiosarcoma on chemical shift subtraction magnetic resonance imaging (CSS-MRI): A case report Article / By Wiley Knowledge Hub Characteristic findings of primary perirenal angiosarcoma on chemical shift subtraction magnetic resonance imaging (CSS-MRI): A case report Read More »
Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology Article / By Wiley Knowledge Hub Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology Read More »
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis Article / By Wiley Knowledge Hub A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis Read More »
Resection of previously inoperable retroperitoneal liposarcoma Article / By Wiley Knowledge Hub Resection of previously inoperable retroperitoneal liposarcoma Read More »
Low local recurrence rates following marginal surgical resection of non-coelomic Atypical Lipomatous Tumours/Well-differentiated Liposarcomas Article / By Wiley Knowledge Hub Low local recurrence rates following marginal surgical resection of non-coelomic Atypical Lipomatous Tumours/Well-differentiated Liposarcomas Read More »
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A Article / By Wiley Knowledge Hub Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A Read More »
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma Article / By Wiley Knowledge Hub Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma Read More »
Gender Differences in Prognosis After Primary Resection for Retroperitoneal Liposarcoma Article / By Wiley Knowledge Hub Gender Differences in Prognosis After Primary Resection for Retroperitoneal Liposarcoma Read More »
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma Article / By Wiley Knowledge Hub IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma Read More »
